Published in Br J Pharmacol on October 01, 1992
A potent nonpeptide antagonist of the substance P (NK1) receptor. Science (1991) 4.06
Species differences in affinities of non-peptide antagonists for substance P receptors. Eur J Pharmacol (1991) 1.95
Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345. Br J Pharmacol (1991) 1.86
Substance P and capsaicin-induced contraction of human bronchi. Acta Physiol Scand (1983) 1.59
Neuropeptides in the respiratory tract. Part I. Am Rev Respir Dis (1991) 1.35
Receptors mediating tachykinin-induced contractile responses in guinea-pig trachea. Br J Pharmacol (1991) 1.33
VIP and PHM and their role in nonadrenergic inhibitory responses in isolated human airways. J Appl Physiol (1985) (1986) 1.30
Relative potencies of neurokinins in guinea pig trachea and human bronchus. Eur J Pharmacol (1987) 1.22
Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonist. Science (1991) 1.17
Selectivity and specificity of new, non-peptide, quinuclidine antagonists of substance P. Biochem Biophys Res Commun (1991) 1.10
Characterization of a tachykinin peptide NK2 receptor transfected into murine fibroblast B82 cells. Proc Natl Acad Sci U S A (1991) 1.00
Potentiation of the contractile effects of neuropeptides in human bronchus by an enkephalinase inhibitor. Pulm Pharmacol (1988) 0.96
Radioiodinated substance P, neurokinin A, and eledoisin bind predominantly in NK1 receptors in guinea pig lung. Mol Pharmacol (1992) 0.92
Concepts in characterization of tachykinin receptors. Ann N Y Acad Sci (1991) 0.92
Relationship between smooth muscle volume and contractile response in airway tissue. Isometric versus isotonic measurement. J Pharmacol Exp Ther (1988) 0.89
Distribution of substance P receptors in rabbit airways, functional and autoradiographic studies. J Pharmacol Exp Ther (1990) 0.89
Selective agonists of NK-2 binding sites highly active on rat portal vein (NK-3 bioassay). Neuropeptides (1991) 0.88
Neurokinin A with K+ channel blockade potentiates contraction to electrical stimulation in human bronchus. Eur J Pharmacol (1990) 0.86
NK-2 receptor agonists and antagonists. Ann N Y Acad Sci (1991) 0.85
Neuropeptide gamma, the most potent contractile tachykinin in human isolated bronchus, acts via a 'non-classical' NK2 receptor. Neuropeptides (1991) 0.82
Both neurokinin A and substance P bind to NK1 receptors in guinea-pig lung. Pulm Pharmacol (1989) 0.81
Effect of tachykinins in small human airways. Neuropeptides (1991) 0.78
Histamine and carbachol contractile responses in proximal and distal airways of the rabbit. Clin Exp Pharmacol Physiol (1985) 0.78
An African primate lentivirus (SIVsm) closely related to HIV-2. Nature (1989) 5.03
The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc Natl Acad Sci U S A (1987) 4.93
Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proc Natl Acad Sci U S A (1986) 4.14
SIV adaptation to human cells. Nature (1989) 3.09
Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication. J Virol (1995) 2.96
Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival. J Virol (1997) 2.81
Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum Gene Ther (1999) 2.73
Species-specific diversity among simian immunodeficiency viruses from African green monkeys. J Virol (1991) 2.70
Diet-induced adipocyte number increase in adult rats: a new model of obesity. Am J Physiol (1978) 2.62
Loss of functional KATP channels in pancreatic beta-cells causes persistent hyperinsulinemic hypoglycemia of infancy. Nat Med (1996) 2.40
Pathogenic diversity of simian immunodeficiency viruses. Virus Res (1994) 2.27
Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity. J Virol (1987) 2.26
Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses. Proc Natl Acad Sci U S A (1989) 2.21
Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles. J Virol (2000) 2.09
TENTATIVE CLASSIFICATION OF SYMPTOMATIC TYPES OF "TOMATO POCKETS". Plant Physiol (1930) 2.00
Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J Infect Dis (1986) 1.97
Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle. Hum Gene Ther (1997) 1.93
Molecular cloning of feline immunodeficiency virus. Proc Natl Acad Sci U S A (1989) 1.92
Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine. J Med Virol (1985) 1.88
Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile. Immunol Lett (1996) 1.87
Cellularity of adipose depots in six strains of genetically obese mice. J Lipid Res (1972) 1.84
Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Science (1990) 1.79
Neurochemical classification of myenteric neurons in the guinea-pig ileum. Neuroscience (1996) 1.78
Changing nature of physician satisfaction with health maintenance organization and fee-for-service practices. J Fam Pract (1997) 1.72
The two open reading frames of the 22K mRNA of human respiratory syncytial virus: sequence comparison of antigenic subgroups A and B and expression in vitro. J Gen Virol (1990) 1.71
Gene overlap and site-specific attenuation of transcription of the viral polymerase L gene of human respiratory syncytial virus. Proc Natl Acad Sci U S A (1987) 1.69
SUMO-1: Ubiquitin gains weight. Trends Cell Biol (1997) 1.68
Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression. Hum Gene Ther (1999) 1.67
Cell lines for the production of recombinant adeno-associated virus. Hum Gene Ther (1995) 1.62
A highly divergent proviral DNA clone of SIV from a distinct species of African green monkey. Virology (1991) 1.61
A distinct African lentivirus from Sykes' monkeys. J Virol (1993) 1.58
Selective infection of human CD4+ cells by simian immunodeficiency virus: productive infection associated with envelope glycoprotein-induced fusion. Proc Natl Acad Sci U S A (1989) 1.56
Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med (1997) 1.55
Sensitization alters contractile responses and calcium influx in human airway smooth muscle. J Allergy Clin Immunol (1989) 1.55
Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector. Science (1992) 1.54
Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab (1996) 1.53
A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors. Gene Ther (1996) 1.52
Histamine and tryptase modulate asthmatic airway smooth muscle GM-CSF and RANTES release. Eur Respir J (2007) 1.51
Identification of a new subgroup of SIVagm in tantalus monkeys. Virology (1993) 1.50
Multiple viral determinants contribute to pathogenicity of the acutely lethal simian immunodeficiency virus SIVsmmPBj variant. J Virol (1993) 1.49
Somatostatin release, electrical activity, membrane currents and exocytosis in human pancreatic delta cells. Diabetologia (2009) 1.46
Platelet-activating factor-induced contraction of human isolated bronchus. Eur Respir J (1992) 1.45
Double blind randomised controlled trial of two different breathing techniques in the management of asthma. Thorax (2006) 1.45
The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med (2007) 1.43
Entangled macroscopic quantum States in two superconducting qubits. Science (2003) 1.41
Mitozantrone and cytosine arabinoside as first-line therapy in elderly patients with acute myeloid leukaemia. Br J Haematol (1991) 1.40
CXCL1 is a negative regulator of mast cell chemotaxis to airway smooth muscle cell products in vitro. Clin Exp Allergy (2014) 1.39
Spontaneous substitutions in the vicinity of the V3 analog affect cell tropism and pathogenicity of simian immunodeficiency virus. J Virol (1994) 1.39
Rhabdomyosarcoma presenting as 'acute leukaemia'. Histopathology (1991) 1.38
Simian immunodeficiency virus infection of macaques: end-stage disease is characterized by widespread distribution of proviral DNA in tissues. J Infect Dis (1991) 1.36
The small hydrophobic protein of human respiratory syncytial virus: comparison between antigenic subgroups A and B. J Gen Virol (1990) 1.32
Effects of innate immunity on herpes simplex virus and its ability to kill tumor cells. Gene Ther (2003) 1.31
The action of a potassium channel activator, BRL 38227 (lemakalim), on human airway smooth muscle. Am Rev Respir Dis (1990) 1.30
SIV from stump-tailed macaques: molecular characterization of a highly transmissible primate lentivirus. Virology (1992) 1.29
Novel pharmacology of substance K-binding sites: a third type of tachykinin receptor. Science (1984) 1.26
Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection. Virology (1994) 1.25
The mechanism of action of endothelin in human lung. Br J Pharmacol (1991) 1.22
Responsiveness of bronchial smooth muscle from asthmatic patients to relaxant and contractile agonists. Pulm Pharmacol (1988) 1.22
Cellularity of adipose depots in the genetically obese Zucker rat. J Lipid Res (1971) 1.22
Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaques. J Virol (1990) 1.20
Using the polymerase chain reaction to genotype human papillomavirus DNAs in samples containing multiple HPVs may produce inaccurate results. J Virol Methods (1993) 1.18
Ionic control of beta cell function in nesidioblastosis. A possible therapeutic role for calcium channel blockade. Arch Dis Child (1996) 1.14
Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine. J Infect Dis (1994) 1.13
Release of ATP from rat urinary bladder mucosa: role of acid, vanilloids and stretch. Br J Pharmacol (2009) 1.12
Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder. J Pharmacol Exp Ther (1986) 1.12
Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines. Mol Ther (2000) 1.12
Brief periods of hyperphagia cause renal injury in the obese Zucker rat. Kidney Int (1999) 1.08
Comparison of in vivo and in vitro responses to histamine in human airways. Am Rev Respir Dis (1983) 1.07
A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells. J Immunol (1999) 1.05
Tachykinin receptors: a radioligand binding perspective. J Neurochem (1993) 1.04
The Saccharomyces cerevisiae ubiquitin-proteasome system. Philos Trans R Soc Lond B Biol Sci (1999) 1.04
The simian immunodeficiency virus envelope glycoprotein contains two epitopes presented by the Mamu-A*01 class I molecule. J Virol (1999) 1.04
Roles of neuronal NK1 and NK3 receptors in synaptic transmission during motility reflexes in the guinea-pig ileum. Br J Pharmacol (1998) 1.03
Animal models for acquired immunodeficiency syndrome. Adv Immunol (1992) 1.02
Molecular cloning of SIV from sooty mangabey monkeys. J Med Primatol (1989) 1.02
Spontaneous activity and adipose cellularity in the genetically obese Zucker rat (fafa). Metabolism (1977) 1.02
Mast cell migration to Th2 stimulated airway smooth muscle from asthmatics. Thorax (2006) 1.01
Characterization of contractile prostanoid receptors on human airway smooth muscle. Eur J Pharmacol (1989) 1.01
ERK activation and mitogenesis in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2001) 1.00
Gene transfer into the CNS using recombinant adeno-associated virus: analysis of vector DNA forms resulting in sustained expression. J Drug Target (1999) 1.00
Smooth-muscle myosin light-chain kinase content is increased in human sensitized airways. Am J Respir Crit Care Med (2000) 0.99
Human mast cell and airway smooth muscle cell interactions: implications for asthma. Am J Physiol Lung Cell Mol Physiol (2001) 0.98
Gene delivery of vaccines for infectious disease. Curr Opin Mol Ther (2001) 0.98
Mast cell tryptase potentiates histamine-induced contraction in human sensitized bronchus. Eur Respir J (1997) 0.98
Correlation of NADH and Ca2+ signals in mouse pancreatic acinar cells. J Physiol (2002) 0.97
Interleukin-4 inhibits mitogen-induced proliferation of human airway smooth muscle cells in culture. Am J Physiol (1998) 0.97
Heparin and PGE2 inhibit DNA synthesis in human airway smooth muscle cells in culture. Am J Physiol (1995) 0.97
Insulin resistance and pancreatic insulin release in the genetically obese Zucker rat. Proc Soc Exp Biol Med (1972) 0.97
Human pancreatic islet isolation and transplantation. Clin Transplant (1994) 0.97
Adipose tissue regeneration following lipectomy. Science (1977) 0.96
Potentiation of the contractile effects of neuropeptides in human bronchus by an enkephalinase inhibitor. Pulm Pharmacol (1988) 0.96
Multiple tachykinin binding sites in hamster, rat and guinea-pig urinary bladder. Eur J Pharmacol (1986) 0.96
Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus. Gene Ther (1999) 0.96
The chemistry of site-directed serology for HIV infections. AIDS Res Hum Retroviruses (1989) 0.95
A comparison of in vivo and in vitro human airway reactivity to histamine. Am Rev Respir Dis (1984) 0.95
Therapy for persistent hyperinsulinemic hypoglycemia of infancy. Understanding the responsiveness of beta cells to diazoxide and somatostatin. J Clin Invest (1997) 0.95